Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack

被引:5
作者
Scalia, Lorenzo [1 ]
Calderone, Dario [1 ]
Capodanno, Davide [1 ]
机构
[1] Univ Catania, Azienda Osped Univ Policlin G Rodolico San Marco, Div Cardiol, Via Santa Sofia 78, I-95100 Catania, Italy
关键词
Antithrombotic therapy; cerebrovascular events; prevention; stroke; transient ischemic attack; ASPIRIN PLUS DIPYRIDAMOLE; HEALTH-CARE PROFESSIONALS; INDIVIDUAL PATIENT DATA; HIGH-RISK PATIENTS; SECONDARY PREVENTION; OPEN-LABEL; FACTOR-XI; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIALS; CEREBRAL-ISCHEMIA;
D O I
10.1080/17512433.2022.2118713
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Antiplatelet therapy is key to prevent recurrences in patients with an acute or prior non-cardioembolic stroke or transient ischemic attack (TIA). The narrow balance between the risks of ischemic recurrence and major bleeding is a relevant clinical dilemma in this population. Areas covered This review covers the current evidence on antiplatelet therapy for patients with non-cardioembolic stroke or TIA. Randomized controlled trials of antithrombotic strategies for patients with these conditions were searched in Pubmed/Medline from 1970 to 2022. Expert opinion Numerous randomized controlled trials have defined the current indications to the use of antiplatelet drugs for patients with non-cardioembolic ischemic stroke or TIA. For the management of these subjects, single antiplatelet therapy with aspirin or clopidogrel, or the combination of aspirin and dipyridamole, is usually recommended. After an acute stroke or TIA, a short course of dual antiplatelet therapy with aspirin in combination with clopidogrel or ticagrelor should be considered. The risk of bleeding might be higher with ticagrelor, but a direct comparison with clopidogrel is not available in this setting. The introduction of newer strategies, such as dual-pathway inhibition with aspirin and a direct oral anticoagulant (including emerging factor XI inhibitors under clinical development) may open a new research avenue in this challenging area.
引用
收藏
页码:1027 / 1038
页数:12
相关论文
共 77 条
[1]   2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) [J].
Aboyans, Victor ;
Ricco, Jean-Baptiste ;
Bartelink, Marie-Louise E. L. ;
Bjorck, Martin ;
Brodmann, Marianne ;
Cohnert, Tina ;
Collet, Jean-Philippe ;
Czerny, Martin ;
De Carlo, Marco ;
Debus, Sebastian ;
Espinola-Klein, Christine ;
Kahan, Thomas ;
Kownator, Serge ;
Mazzolai, Lucia ;
Naylor, A. Ross ;
Roffi, Marco ;
Roether, Joachim ;
Sprynger, Muriel ;
Tendera, Michal ;
Tepe, Gunnar ;
Venermo, Maarit ;
Vlachopoulos, Charalambos ;
Desormais, Ileana .
EUROPEAN HEART JOURNAL, 2018, 39 (09) :763-+
[2]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[3]   A CRITICAL EVALUATION OF EXERCISE TESTING IN DIAGNOSING PERIPHERAL ARTERY DISEASE [J].
Aday, Aaron W. ;
Kinlay, Scott ;
Gerhard-Herman, Marie .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) :2002-2002
[4]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[5]   Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin [J].
Amarenco, Pierre ;
Denison, Hans ;
Evans, Scott R. ;
Himmelmann, Anders ;
James, Stefan ;
Knutsson, Mikael ;
Ladenvall, Per ;
Molina, Carlos A. ;
Wang, Yongjun ;
Johnston, S. Claiborne .
STROKE, 2020, 51 (12) :3504-3513
[6]   Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial [J].
Amarenco, Pierre ;
Albers, Gregory W. ;
Denison, Hans ;
Easton, J. Donald ;
Evans, Scott R. ;
Held, Peter ;
Hill, Michael D. ;
Jonasson, Jenny ;
Kasner, Scott E. ;
Ladenvall, Per ;
Minematsu, Kazuo ;
Molina, Carlos A. ;
Wang, Yongjun ;
Wong, K. S. Lawrence ;
Johnston, S. Claiborne .
LANCET NEUROLOGY, 2017, 16 (04) :301-310
[7]   Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development [J].
Angiolillo, Dominick J. ;
Suryadevara, Siva ;
Capranzano, Piera ;
Bass, Theodore A. .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (16) :2893-2900
[8]   Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel The ABCD-GENE Score [J].
Angiolillo, Dominick J. ;
Capodanno, Davide ;
Danchin, Nicolas ;
Simon, Tabassome ;
Bergmeijer, Thomas O. ;
ten Berg, Jurrien M. ;
Sibbing, Dirk ;
Price, Matthew J. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (05) :606-617
[9]  
[Anonymous], 1987, LANCET, V2, P1351
[10]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71